Across the past 12 months, Apyx Medical insiders reported no open-market purchases or sales.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Stavros G. Vizirgianakis | Director | 2,196,191 | 0 | 2,196,191 | 63.0% | 15 Jun, 2026 |
| 2 | Andrew Makrides | Ceo | 624,389 | 0 | 624,389 | 17.9% | 11 Jul, 2022 |
| 3 | Moshe Citronowicz | Senior Vice President | 493,504 | 0 | 493,504 | 14.2% | 17 Mar, 2026 |
| 4 | Charles D. Ii Goodwin | Chief Executive Officer | 90,000 | 0 | 90,000 | 2.6% | 15 Nov, 2023 |
| 5 | Michael Geraghty | Director | 27,500 | 0 | 27,500 | 0.8% | 08 Jun, 2023 |
| 6 | Craig A. Swandal | Director | 17,000 | 0 | 17,000 | 0.5% | 21 Mar, 2022 |
| 7 | Shawn David Roman | Chief Operating Officer | 0 | 16,467 | 16,467 | 0.5% | 17 Jun, 2026 |
| 8 | Lawrence Waldman | Director | 0 | 12,314 | 12,314 | 0.4% | 02 Jul, 2026 |
| 9 | Matthew C Hill | Chief Financial Officer | 7,836 | 0 | 7,836 | 0.2% | 13 Aug, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 30 Jun, 2026 | Lawrence Waldman | Director | Acquired M | 12,000 | $1.88 | $22.56K | 17,338 | Indirect |
| 30 Jun, 2026 | Lawrence Waldman | Director | Disposed F | 5,024 | $4.49 | $22.56K | 12,314 | Indirect |
| 30 Jun, 2026 | Lawrence Waldman | Director | Disposed M | 12,000 | $0.00 | $0 | 0 | Indirect |
| 15 Jun, 2026 | Shawn David Roman | Chief Operating Officer | Acquired M | 15,000 | $3.23 | $48.45K | 15,000 | Indirect |
| 15 Jun, 2026 | Shawn David Roman | Chief Operating Officer | Disposed F | 10,533 | $4.60 | $48.45K | 16,467 | Indirect |
| 15 Jun, 2026 | Shawn David Roman | Chief Operating Officer | Disposed M | 15,000 | $0.00 | $0 | 0 | Direct |
| 11 Jun, 2026 | Lawrence Waldman | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 11 Jun, 2026 | Charles D. Ii Goodwin | Chief Executive Officer | Acquired A | 213,948 | $0.00 | $0 | 213,948 | Direct |
| 11 Jun, 2026 | Matthew C Hill | Chief Financial Officer | Acquired A | 132,066 | $0.00 | $0 | 132,066 | Direct |
| 11 Jun, 2026 | Moshe Citronowicz | Sr. V.P. Of Operations | Acquired A | 63,392 | $0.00 | $0 | 63,392 | Direct |
| 11 Jun, 2026 | Wendy Lauren Levine | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 11 Jun, 2026 | Minnie Baylor-Henry | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 11 Jun, 2026 | Stavros G. Vizirgianakis | Director | Acquired A | 450,000 | $0.00 | $0 | 2,196,191 | Direct |
| 11 Jun, 2026 | Shawn David Roman | Chief Operating Officer | Acquired A | 88,044 | $0.00 | $0 | 88,044 | Direct |
| 15 Mar, 2026 | Moshe Citronowicz | Senior Vice President | Acquired M | 37,000 | $1.80 | $66.60K | 493,504 | Direct |
| 15 Mar, 2026 | Moshe Citronowicz | Senior Vice President | Disposed M | 37,000 | $0.00 | $0 | 0 | Direct |
| 27 Jan, 2026 | Shawn David Roman | Chief Operating Officer | Acquired M | 12,000 | $1.80 | $21.60K | 12,000 | Indirect |
| 27 Jan, 2026 | Shawn David Roman | Chief Operating Officer | Disposed M | 12,000 | $0.00 | $0 | 0 | Direct |
| 15 May, 2025 | Moshe Citronowicz | Sr. V.P. Of Operations | Acquired A | 36,000 | $0.00 | $0 | 36,000 | Direct |
| 15 May, 2025 | Lawrence Waldman | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |